E-LIB Suche - Ergebnisse für: Janmaat, Maarten

1

P816: PHARMACODYNAMIC ACTIVITY OF GEN3014 (HEXABODY-CD38) I..:

Hiemstra, Ida H. ; Santegoets, Kim ; Janmaat, Maarten...
HemaSphere. 7 (2023) S3 - p. e008261b , 2023

Link: https://doi.org/10.1097/..

2

Preclinical anti-tumour activity of HexaBody-CD38, a next-g..:

Hiemstra, Ida H. ; Santegoets, Kim C.M. ; Janmaat, Maarten L....
eBioMedicine. 93 (2023) - p. 104663 , 2023

Link: https://doi.org/10.1016/..

3

Mechanistic and pharmacodynamic studies of DuoBody-CD3x5T4 ..:

Kemper, Kristel ; Gielen, Ellis ; Boross, Peter...
Life Science Alliance. 5 (2022) 11 - p. e202201481 , 2022

Link: https://doi.org/10.26508..

4

Hinge-deleted IgG4 blocker therapy for acetylcholine recept..:

Losen, Mario ; Labrijn, Aran F. ; van Kranen-Mastenbroek, Vivianne H....
Scientific Reports. 7 (2017) 1 - p. , 2017

Link: https://doi.org/10.1038/..

5

Monoclonal antibodies targeting CD38 in hematological malig..:

van de Donk, Niels W. C. J. ; Janmaat, Maarten L. ; Mutis, Tuna...
Immunological Reviews. 270 (2016) 1 - p. 95-112 , 2016

Link: https://doi.org/10.1111/..

6

Basic Fibroblast Growth Factor-Mediated Overexpression of V..:

Fontijn, Dennis ; Bosch, Linda J. W. ; Duyndam, Monique C. A....
Analytical Cellular Pathology. 31 (2009) 3 - p. 179-190 , 2009

Link: https://doi.org/10.1155/..

7

Interaction between celecoxib and docetaxel or cisplatin in..:

Bijman, Marcel N.A. ; Hermelink, Cristian A. ; van Berkel, Maria P.A....
Biochemical Pharmacology. 75 (2008) 2 - p. 427-437 , 2008

Link: https://doi.org/10.1016/..

8

Enhanced cytotoxicity induced by gefitinib and specific inh..:

Janmaat, Maarten L. ; Rodriguez, José A. ; Gallegos‐Ruiz, Mariëlle..
International Journal of Cancer. 118 (2005) 1 - p. 209-214 , 2005

Link: https://doi.org/10.1002/..

9

Small-Molecule Epidermal Growth Factor Receptor Tyrosine Ki..:

Janmaat, Maarten L. ; Giaccone, Giuseppe
The Oncologist. 8 (2003) 6 - p. 576-586 , 2003

Link: https://doi.org/10.1634/..

10

Preclinical anti-tumour activity of HexaBody-CD38, a next-g..:

Hiemstra, Ida H ; Santegoets, Kim C.M ; Janmaat, Maarten L...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10320249/. , 2023

Link: http://www.ncbi.nlm.nih...

11

P816: PHARMACODYNAMIC ACTIVITY OF GEN3014 (HEXABODY-CD38) I..:

Hiemstra, Ida H ; Santegoets, Kim ; Janmaat, Maarten...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430752/. , 2023

Link: http://www.ncbi.nlm.nih...

12

Mechanistic and pharmacodynamic studies of DuoBody-CD3x5T4 ..:

Kemper, Kristel ; Gielen, Ellis ; Boross, Peter...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9458754/. , 2022

Link: http://www.ncbi.nlm.nih...

13

Enapotamab vedotin, an AXL-specific antibody-drug conjugate..:

Koopman, Louise A ; Terp, Mikkel G ; Zom, Gijs G...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6948776/. , 2019

Link: http://www.ncbi.nlm.nih...

14

Enapotamab vedotin, an AXL-specific antibody-drug conjugate..:

Koopman, Louise A ; Terp, Mikkel G ; Zom, Gijs G...
Koopman , L A , Terp , M G , Zom , G G , Janmaat , M L , Jacobsen , K , Van Den Heuvel , E G , Brandhorst , M , Forssmann , U , De Bree , F , Pencheva , N , Lingnau , A , Zipeto , M A , Parren , P W H I , Breij , E C W & Ditzel , H J 2019 , ' Enapotamab vedotin, an AXL-specific antibody-drug conjugate, shows preclinical antitumor activity in non-small cell lung cancer ' , JCI Insight , vol. 4 , no. 21 , e128199 . https://doi.org/10.1172/jci.insight.128199. , 2019

Link: https://portal.findresea..

15

Hinge-deleted IgG4 blocker therapy for acetylcholine recept..:

Losen, Mario ; Labrijn, Aran F ; van Kranen-Mastenbroek, Vivianne H...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5430546/. , 2017

Link: http://www.ncbi.nlm.nih...